Tissue remodelling in liver diseases

Area of Science:

• Hepatology
• Cell Biology
• Pathology

Background:

• Tissue remodelling is a fundamental biological process affecting tissue structure and function.
• It occurs in both physiological states (e.g., pregnancy) and pathological conditions (e.g., wound healing).
• Liver remodelling is particularly relevant in chronic hepatitis and hepatocellular carcinoma (HCC).

Purpose of the Study:

• To review liver tissue remodelling in the context of chronic inflammation and HCC.
• To explore the role of extracellular matrix (ECM) deposition and turnover in liver fibrosis and cirrhosis.
• To evaluate the impact of cytokines, including Interferon-alpha, on ECM proteolysis and their therapeutic potential.

Main Methods:

• Review of existing literature on liver remodelling, fibrosis, cirrhosis, and HCC.
• Analysis of the mechanisms underlying ECM alterations in liver disease.
• Evaluation of the role of inflammatory and anti-inflammatory cytokines in modulating ECM proteolysis.

Main Results:

• Altered ECM deposition and turnover are key drivers of liver fibrosis, potentially leading to cirrhosis.
• Cytokines, such as Interferon-alpha, can modulate ECM proteolysis, offering therapeutic avenues.
• Alterations in the liver microenvironment, including ECM and growth factors, are implicated in HCC development and invasiveness.

Conclusions:

• Liver remodelling is a critical process in the pathogenesis of chronic liver diseases and HCC.
• Targeting ECM dynamics and cytokine signaling represents a promising therapeutic strategy for liver fibrosis and cancer.
• Understanding the interplay between the microenvironment and liver disease progression is essential for developing effective treatments.